Puneet Mohan

Author PubWeight™ 35.60^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Apixaban versus warfarin in patients with atrial fibrillation.	N Engl J Med	2011	23.50
2	Apixaban with antiplatelet therapy after acute coronary syndrome.	N Engl J Med	2011	4.81
3	Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.	Lancet Neurol	2012	1.99
4	Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.	Lancet	2012	1.83
5	Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.	Circulation	2009	1.60
6	Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban--an oral, direct and selective factor Xa inhibitor.	J Thromb Thrombolysis	2011	1.12
7	High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.	Circulation	2013	0.99
8	Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.	Thromb Haemost	2010	0.81
9	Apixaban decreases coagulation activity in patients with acute deep-vein thrombosis.	Thromb Haemost	2010	0.76
10	Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.	Ann N Y Acad Sci	2014	0.76